COVID-19 and Cardiac Arrhythmias: a Contemporary Review.
Sandeep A SahaAndrea M RussoMina K ChungThomas F DeeringDhanunjaya LakkireddyRakesh Gopinathan NairPublished in: Current treatment options in cardiovascular medicine (2022)
Arrhythmic complications from acute COVID-19 infection are commonly encountered in clinical practice, and COVID-19 patients with cardiac complications tend to have worse clinical outcomes than those without. Management of these arrhythmias should be based on published evidence-based guidelines, with special consideration of the acuity of COVID-19 infection, concomitant use of antimicrobial and anti-inflammatory drugs, and the transient nature of some rhythm disorders. Some manifestations, such as the long COVID syndrome, may lead to residual symptoms several months after acute infection. As the pandemic evolves with the discovery of new SARS-CoV2 variants, development and use of newer anti-viral and immuno-modulator drugs, and the increasing adoption of vaccination, clinicians must remain vigilant for other arrhythmic manifestations that may occur in association with this novel but potentially deadly disease.
Keyphrases
- sars cov
- coronavirus disease
- clinical practice
- respiratory syndrome coronavirus
- anti inflammatory drugs
- left ventricular
- risk factors
- small molecule
- palliative care
- liver failure
- congenital heart disease
- dna methylation
- high throughput
- electronic health record
- intensive care unit
- gene expression
- randomized controlled trial
- blood pressure
- respiratory failure
- brain injury
- sleep quality
- genome wide